Why U.S. stocks keep hitting records as yield curve flattens

image

U.S. stock benchmarks rose to record highs Thursday as investors appeared to shrug off concerns over growth and inflation as the economy recovers from the pandemic.

Although rates are moving up and inflation is higher, that really isn’t being reflected in longer-term Treasury yields, Ralph Bassett, head of North American equities at abrdn told MarketWatch on Thursday. Within the stock market, “I think that’s why you see, more broadly, strength in technology today,” he said by phone.

Tech and high-growth companies are viewed as particularly sensitive to rising interest rates, a concern investors have been weighing in recent months as they watch for any shifts by the Federal Reserve toward tightening its monetary policy through rate hikes, according to Bassett.

The bond market’s yield curve has flattened as investors price in a tightening cycle, said Tom Graff, head of fixed income at Brown Advisory, in a phone interview Thursday. But while rates on the short end of the curve have risen, the long end hasn’t steepened, as the market appears to expect that inflation will be kept under control by the Fed, he told MarketWatch.

“Markets are pretty convinced that it won’t take much to wrangle the recent inflation spike,” Graff said. As for his own expectations for Fed policy, he said he is “leaning toward” two rate hikes by the central bank next year after completing the tapering of its monthly bond purchases by mid-2022.

Rate hikes are a tool the Fed may use to knock down inflation, though some worry doing so will kill the economic recovery.

Earlier this year, investors were worrying about growth peaking during the second quarter, with risks of stagflation moving onto the radar screens of some market analysts as the delta-variant wave of the coronavirus was beginning to surge in the U.S. While delta hurt the economy in the third quarter, COVID-19 cases appear to be subsiding and some investors expect that growth in 2022 will remain above the long-term trend in the U.S.

See: U.S. economy stumbles in third quarter

“Next year we should still exhibit outsized growth given the resurgence of the economy,” said Bassett. While inflationary pressures remain a concern for the economy and corporate profit margins, he said that stagflation worries seem to be largely “brushed off” by the market lately.

Read: Why it’s wrong to compare today’s inflation surge to 1970s-style ‘stagflation’

Bassett told MarketWatch that he expects the Fed to begin tapering this year and to hike rates twice in 2022, beginning in June. Rising rates are a concern for high-growth equities, as Treasury yields feed into models used to calculate their valuations. Higher discount rates make those valuations appear lower, he explained.

Investors typically use the 10-year Treasury yield he added, which has dipped in recent days. The yield on the 10-year Treasury note traded around 1.57% Thursday, down from about 1.67% a week ago, according to Dow Jones Market Data.

Navigating the economic recovery in the pandemic has been somewhat difficult for investors.

“It’s really hard to decipher what is true underlying growth,” said Bassett, partly because of government stimulus but also due to supply-chain constraints that have “curtailed” demand.

Graff also pointed to “mixed signals right now” from many moving parts of the rebound, saying the “sugar rush” of growth will come down but the economic recovery probably will remain “strong” next year.

With the Federal Open Market Committee meeting scheduled next week, Graff said he will be listening closely to Fed Chair Jerome Powell’s messaging on the progress the central bank sees in the labor market as part of its dual mandate in setting monetary policy.

“I just think it’s a pipe dream” that there’s a “magic moment” where all the people who dropped out of the labor market are suddenly coming back, said Graff. “Labor looks pretty tight to me.”

Editor’s note: This story has been updated to reflect the recent name change of Aberdeen Standard Investments to abrdn.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More